Novellus Therapeutics
These guys changed their url and launched a new website. In doing so, they added icons for their menu items. What icon did they choose for their drug pipeline page? An actual piece of pipe. No points for imagination, but can't really fault them.
EQRx
Just paid $150M for a prospective drug after getting funded with $200M in January. Their big coming out party in January was wrapped up in the fact that they would have 10 drugs approved in 10 years and they would be sold cheaply. That was crazy then and it seems even crazier now. If we read this right, their execution strategy is:
-get investor money
-sit on it for nine months while getting paid a salary
-buy a potential drug for which there are many existing competitors
-charge less
-profit?
Yeah, right. There are all sorts of zany investments out there in biotech right now, but investing in a company focusing on low-margin, high-competition markets is about as foolish as you could possibly come up with. #NotMyMoney
Asedas Sciences
We first recorded this company's website as being down in August. They now have a countdown to re-launch going - midnight on November 15 is the anointed moment. For a company to be that confident in a relaunch moment after having a website totally offline for months is kinda funny.
Anyways, not sure what the point of all this is - you're supposed to design a new website and when it's finished you just replace the old with the new which comes with basically zero downtime.
And yet who among us can now say they aren't totally hyped for November 15th, 2020?